MedTrace Logo

Pilot Study of 18F-FLT PET

NCT00585741 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2012-02-23

No results posted yet for this study

Summary

Fractionated radiotherapy induces an observable change in the proliferative activity as assessed by pre-treatment and early-treatment 18F-FLT PET imaging. This study is designed to investigate 18F-FLT as a PET imaging agent for predicting treatment effectiveness in several tumors and will serve as a pilot study to a planned PO1 submission

Conditions

Interventions

PROCEDURE

Imaging with 18F-FLT PET

Imaging with 18F-FLT PET

PROCEDURE

Imaging with 18F-FLT PET

Imaging with 18F-FLT PET

PROCEDURE

Imaging with 18F-FLT PET

Imaging with 18F-FLT PET

PROCEDURE

Imaging with 18F-FLT PET

Imaging with 18F-FLT PET

PROCEDURE

Imaging with 18F-FLT PET

Imaging with 18F-FLT PET

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Robert Jeraj, Ph.D. · University of Wisconsin, Madison

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00585741 on ClinicalTrials.gov